HCA
$459.14-1.42%
as of close, Oct 21, 2026
☾ AH $459.14 -1.42%
HCA financial statements
The full income statement, balance sheet, and cash-flow statement for HCA Healthcare Inc. (HCA), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 258.1M2024-09 253.3M2024-12 248.3M2025-03 240.6M2025-06 234.0M2025-09 228.2M2025-12 223.6M2026-03 221.8M2026-06 216.5M-16.1% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 75.6B+7.1% | 70.6B+8.7% | 65.0B+7.9% | 60.2B+2.5% | 58.8B+14.0% | |
| Selling, general & administrative | 548M+30.2% | 421M+19.3% | 353M+15.0% | 307M-8.9% | 337M-19.0% | |
| General & administrative | 548M+30.2% | 421M+19.3% | 353M+15.0% | 307M-8.9% | 337M-19.0% | |
| Amortization of intangibles | 12.0M-25.0% | 16.0M-20.0% | 20.0M-54.5% | 44.0M+76.0% | 25.0M-3.8% | |
| Interest expense | 2.25B+9.1% | 2.06B+6.3% | 1.94B+11.3% | 1.74B+11.2% | 1.57B-1.1% | |
| Equity-method income | 78.0M+239.1% | 23.0M+4.5% | 22.0M-51.1% | 45.0M-60.2% | 113M+109.3% | |
| Pre-tax income | 9.83B+15.4% | 8.52B+10.6% | 7.71B-10.2% | 8.58B-12.7% | 9.83B+81.1% | |
| Income tax | 2.05B+9.9% | 1.87B+15.5% | 1.61B-7.5% | 1.75B-17.3% | 2.11B+102.5% | |
| 6.78B+17.8% | 5.76B+9.9% | 5.24B-7.1% | 5.64B-18.9% | 6.96B+85.3% | ||
| Net income to non-controlling interest | 998M+11.3% | 897M+5.7% | 849M-28.7% | 1.19B+55.7% | 765M+20.9% | |
| $28.33+28.8% | $22.00+16.0% | $18.97-0.9% | $19.15-9.5% | $21.16+93.6% | ||
| EPS (basic) | $28.70+28.9% | $22.27+15.7% | $19.25-0.9% | $19.43-9.7% | $21.52+93.9% | |
| Weighted-avg shares (basic) | 236M-8.6% | 259M-5.1% | 272M-6.2% | 290M-10.2% | 323M-4.4% | |
| Weighted-avg shares (diluted) | 239M-8.5% | 262M-5.3% | 276M-6.2% | 295M-10.4% | 329M-4.3% | |
| Dividends per share | $2.88+9.1% | $2.64+10.0% | $2.40+7.1% | $2.24+16.7% | $1.92+11.6% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 15.8B-3.8% | 16.4B+10.0% | 14.9B+9.4% | 13.6B+0.7% | 13.5B+9.8% | ||
| Cash & equivalents | 1.04B-46.2% | 1.93B+106.7% | 935M+3.0% | 908M-37.4% | 1.45B-19.1% | |
| Accounts receivable | 10.9B+1.1% | 10.8B+8.0% | 9.96B+12.0% | 8.89B+9.8% | 8.10B+14.8% | |
| Inventory | 1.65B-4.9% | 1.74B-14.0% | 2.02B-2.3% | 2.07B+4.1% | 1.99B-1.9% | |
| Other current assets | 2.22B+11.6% | 1.99B-1.0% | 2.01B+13.3% | 1.78B-11.6% | 2.01B+37.3% | |
| 60.7B+2.0% | 59.5B+5.9% | 56.2B+7.2% | 52.4B+3.3% | 50.7B+6.8% | ||
| Property, plant & equipment | 31.1B+5.9% | 29.4B+6.1% | 27.7B+8.4% | 25.6B+6.3% | 24.1B+3.7% | |
| Operating lease right-of-use | 2.13B-0.0% | 2.13B-3.4% | 2.21B+6.9% | 2.06B-2.3% | 2.11B+4.4% | |
| Long-term investments | 485M-14.8% | 569M+19.3% | 477M+25.2% | 381M | — | |
| Other non-current assets | 255M+10.9% | 230M+25.0% | 184M-38.3% | 298M-50.2% | 598M+9.5% | |
| 16.4B+7.7% | 15.2B+19.9% | 12.7B+27.8% | 9.90B+3.3% | 9.58B+10.1% | ||
| Accounts payable | 4.66B+9.0% | 4.28B+1.0% | 4.23B-0.1% | 4.24B+3.1% | 4.11B+16.3% | |
| Short-term & current debt | 4.89B+4.1% | 4.70B+93.8% | 2.42B+555.1% | 370M+56.1% | 237M+13.4% | |
| Current lease liability | 352M+2.6% | 343M-5.5% | 363M-0.3% | 364M-7.1% | 392M+3.4% | |
| Finance lease liability (current) | 133M-17.9% | 162M-2.4% | 166M+26.7% | 131M-8.4% | 143M+11.7% | |
| Long-term debt | 41.6B+8.5% | 38.3B+3.1% | 37.2B-1.4% | 37.7B+9.8% | 34.3B+11.5% | |
| Non-current lease liability | 1.85B-0.5% | 1.86B-2.1% | 1.90B+8.6% | 1.75B-0.2% | 1.75B+4.9% | |
| Operating lease liability (total) | 2.21B-0.0% | 2.21B-2.6% | 2.27B+7.1% | 2.12B-1.4% | 2.15B+4.6% | |
| Finance lease liability (total) | 758M-3.6% | 786M+11.2% | 707M-0.4% | 710M-1.4% | 720M+15.8% | |
| Finance lease liability | 625M+0.2% | 624M+15.3% | 541M-6.6% | 579M+0.3% | 577M+16.8% | |
| -6.03B-141.2% | -2.50B-40.9% | -1.77B+35.9% | -2.77B-196.6% | -933M-263.1% | ||
| Additional paid-in capital | — | — | — | — | 0.00-100.0% | |
| Retained earnings | -5.72B-170.6% | -2.12B-56.4% | -1.35B+40.7% | -2.28B-328.6% | -532M-168.5% | |
| Accumulated other comprehensive income | -305M+21.2% | -387M+8.9% | -425M+13.3% | -490M-21.3% | -404M+19.5% | |
| Non-controlling interest | 3.26B+6.6% | 3.05B+7.8% | 2.83B+5.2% | 2.69B+11.2% | 2.42B+4.4% | |
| Total equity incl. non-controlling | -2.77B-599.3% | 555M-47.6% | 1.06B+1552.1% | -73.0M-104.9% | 1.49B-48.5% | |
| Total liabilities & equity | 60.7B+2.0% | 59.5B+5.9% | 56.2B+7.2% | 52.4B+3.3% | 50.7B+6.8% | |
| Common shares outstanding | 225M-10.2% | 250M-5.9% | 266M-4.3% | 277M-9.2% | 305M-10.0% | |
| Shares outstanding (cover) | 224M-10.0% | 248M-6.1% | 264M-4.5% | 277M-8.8% | 304M-10.7% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 12.6B+20.2% | 10.5B+11.5% | 9.43B+10.7% | 8.52B-4.9% | 8.96B-3.0% | ||
| Depreciation & amortization | 3.52B+6.4% | 3.31B+7.6% | 3.08B+3.6% | 2.97B+4.1% | 2.85B+4.9% | |
| Intangible amortization | 12.0M-25.0% | 16.0M-20.0% | 20.0M-54.5% | 44.0M+76.0% | 25.0M-3.8% | |
| Share-based compensation | 401M+11.4% | 360M+37.4% | 262M-23.2% | 341M-22.5% | 440M+21.5% | |
| Change in receivables | 94.0M-88.2% | 799M-14.5% | 935M+17.3% | 797M-17.2% | 962M+394.2% | |
| -4.99B-1.1% | -4.93B+7.2% | -5.32B-56.9% | -3.39B-28.2% | -2.64B+22.1% | ||
| Capital expenditure | 4.94B+1.4% | 4.88B+2.8% | 4.74B+7.9% | 4.39B+22.9% | 3.58B+26.2% | |
| Free cash flow | 7.69B+36.4% | 5.64B+20.3% | 4.69B+13.6% | 4.13B-23.3% | 5.38B-15.9% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other investing activities | -12.0M-340.0% | 5.00M-73.7% | 19.0M-9.5% | 21.0M+425.0% | 4.00M-89.5% | |
| -8.55B-86.6% | -4.58B-11.9% | -4.09B+27.6% | -5.66B+15.0% | -6.66B-42.3% | ||
| Long-term debt issued | 8.47B+13.1% | 7.50B+132.5% | 3.22B-46.2% | 6.00B+38.1% | 4.34B+60.9% | |
| Long-term debt repaid | 7.39B+206.6% | 2.41B+165.1% | 909M-67.9% | 2.83B-26.9% | 3.87B+12.6% | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 10.1B+66.6% | 6.04B+58.5% | 3.81B-45.6% | 7.00B-14.8% | 8.21B+1762.8% | |
| Dividends paid | 679M-1.6% | 690M+4.4% | 661M+1.2% | 653M+4.6% | 624M+307.8% | |
| Other financing activities | -185M+33.2% | -277M-12.6% | -246M-16.0% | -212M+25.4% | -284M-38.5% | |
| FX effect on cash | 9.00M+1000.0% | -1.00M-114.3% | 7.00M+135.0% | -20.0M-566.7% | -3.00M-130.0% | |
| Net change in cash | -893M-189.5% | 998M+3596.3% | 27.0M+105.0% | -543M-58.8% | -342M-129.2% | |
| Interest paid | 2.21B+13.9% | 1.94B+2.4% | 1.89B+13.8% | 1.66B+10.7% | 1.50B-6.5% | |
| Income taxes paid | 1.74B-5.6% | 1.84B+33.0% | 1.39B+18.0% | 1.18B-46.2% | 2.18B+117.8% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 104B+40.1% | 74.5B+2.9% | 72.5B+6.8% | 67.8B-13.0% | 78.0B+39.5% | |
| P/E | 15.4×+18.9% | 12.9×+2.1% | 12.7×+0.4% | 12.6×+12.5% | 11.2×-24.7% | |
| P/S | 1.4×+30.8% | 1.1×-8.0% | 1.1×+1.1% | 1.1×-14.5% | 1.3×+22.4% | |
| P/FCF | 13.6×+2.7% | 13.2×-20.2% | 16.6×+1.9% | 16.3×+12.1% | 14.5×+65.8% | |
| Earnings yield | 6.5%-15.9% | 7.7%-2.1% | 7.9%-0.4% | 7.9%-11.1% | 8.9%+32.8% | |
| FCF yield | 7.4%-2.6% | 7.6%+25.2% | 6.0%-1.8% | 6.2%-10.8% | 6.9%-39.7% | |
| Dividend yield | 0.62%-29.9% | 0.88%-0.8% | 0.89%-5.0% | 0.93%+24.9% | 0.75%-28.5% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: HCA’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all HCA filings on SEC EDGAR → Not investment advice.